The prevailing Uterotonic Agent Market trends are defined by innovation aimed at improving accessibility and addressing cold-chain limitations. The most impactful trend is the accelerated adoption of heat-stable formulations, primarily Carbetocin, following successful large-scale clinical trials and its subsequent recommendation by the WHO for PPH prevention. This stability is...